Gabriel Hortobagyi

Specialty: Breast Oncology

Location: Unknown

Tier: ELITE

H-Index: 157

Years Active: 0

Hospital Affiliations

• MD Anderson Cancer Center - Faculty

Key Publications

1. "Ribociclib plus Endocrine Therapy in Early Breast Cancer." - N Engl J Med (2024)
2. "Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer." - Ann Surg Oncol (2018)
3. "Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer." - N Engl J Med (2016)
4. "Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer." - N Engl J Med (2022)
5. "Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer." - N Engl J Med (2020)

Knowledge Graph Relationships

Gabriel Hortobagyi is a Breast Oncology specialist affiliated with MD Anderson Cancer Center. Authored 5 scholarly articles.